Skip to Main Content

Paper Details

The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Cancer Cell
127
2018
CB-839, GSK3, Glutamine, Lung, Lung SCCs, Lung Squamous Cell Carcinoma, Phospho-GSK3/, SCC, cancer, glutaminase, human, lung squamous cell carcinoma, mTOR, patient, tumors
Author NameAffiliation
Michael C FishbeinDavid Geffen School of Medicine, University of California los angeles
Maie A St JohnDavid Geffen School of Medicine, University of California los angeles
Nicholas M BernthalDavid Geffen School of Medicine, University of California los angeles
Noah FedermanJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Jane YanagawaDavid Geffen School of Medicine, University of California los angeles
Steven M DubinettDavid Geffen School of Medicine, University of California, USA Jonsson Comprehensive Cancer Center los angeles
Steven M DubinettDavid Geffen School of Medicine, University of California, USA Jonsson Comprehensive Cancer Center los angeles
Heather R ChristofkDavid Geffen School of Medicine, University of California, USA Jonsson Comprehensive Cancer Center, USA university of california los angeles Metabolomics Center
  • 1 - 8

Datasets